Tassilo Volz

5.8k total citations · 1 hit paper
55 papers, 3.2k citations indexed

About

Tassilo Volz is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Tassilo Volz has authored 55 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 42 papers in Hepatology and 10 papers in Molecular Biology. Recurrent topics in Tassilo Volz's work include Hepatitis B Virus Studies (43 papers), Hepatitis C virus research (37 papers) and Liver Disease Diagnosis and Treatment (26 papers). Tassilo Volz is often cited by papers focused on Hepatitis B Virus Studies (43 papers), Hepatitis C virus research (37 papers) and Liver Disease Diagnosis and Treatment (26 papers). Tassilo Volz collaborates with scholars based in Germany, United States and Italy. Tassilo Volz's co-authors include Maura Dandri, Marc Lütgehetmann, Lena Allweiss, Joerg Petersen, Ansgar W. Lohse, Stephan Urban, Katja Giersch, Teresa Pollicino, Janine Kah and Laura Belloni and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Tassilo Volz

53 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

2012 444 citations Lena Allweiss, Tassilo Volz et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tassilo Volz Germany	27	2.6k	2.4k	467	414	312	55	3.2k
Lena Allweiss Germany	25	2.5k 0.9×	2.1k 0.9×	387 0.8×	369 0.9×	287 0.9×	66	2.8k
Zhenchao Gao China	10	1.8k 0.7×	1.3k 0.6×	398 0.9×	282 0.7×	207 0.7×	13	2.1k
Guangwei Xu China	8	2.0k 0.7×	1.5k 0.6×	373 0.8×	291 0.7×	214 0.7×	8	2.2k
Barbara Testoni France	29	1.7k 0.6×	1.4k 0.6×	689 1.5×	232 0.6×	288 0.9×	77	2.3k
Julie Lucifora France	27	1.8k 0.7×	1.4k 0.6×	434 0.9×	388 0.9×	491 1.6×	63	2.3k
Liran Fu China	7	1.5k 0.6×	1.1k 0.5×	365 0.8×	336 0.8×	186 0.6×	12	1.9k
Bernadette Guerra United States	21	1.4k 0.6×	1.5k 0.7×	367 0.8×	295 0.7×	422 1.4×	29	2.2k
Guofeng Cheng United States	20	2.1k 0.8×	2.5k 1.1×	528 1.1×	418 1.0×	310 1.0×	35	3.0k
Michiko Miyamoto Japan	17	2.6k 1.0×	3.2k 1.4×	631 1.4×	392 0.9×	346 1.1×	21	3.7k
Maria Teresa Catanese United States	17	958 0.4×	1.2k 0.5×	473 1.0×	172 0.4×	275 0.9×	24	1.9k

Countries citing papers authored by Tassilo Volz

Since Specialization

Citations

This map shows the geographic impact of Tassilo Volz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tassilo Volz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tassilo Volz more than expected).

Fields of papers citing papers by Tassilo Volz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tassilo Volz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tassilo Volz. The network helps show where Tassilo Volz may publish in the future.

Co-authorship network of co-authors of Tassilo Volz

This figure shows the co-authorship network connecting the top 25 collaborators of Tassilo Volz. A scholar is included among the top collaborators of Tassilo Volz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tassilo Volz. Tassilo Volz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allweiss, Lena, et al.. (2024). Pegylated interferon-alpha treatment in vivo potently reduces all HDV markers in primary human hepatocytes undergoing cell division. Zeitschrift für Gastroenterologie. 62(1). e60–e60. 1 indexed citations

Volz, Tassilo, et al.. (2024). Method for Quantitative HDV RNA Detection: I, Manual Workflow (Serum and Liver Tissue) and II, Fully Automated High Throughput Workflow for Diagnostic Use. Methods in molecular biology. 2837. 171–184.

Giersch, Katja, Nora Goldmann, Tassilo Volz, et al.. (2023). Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment. JHEP Reports. 5(4). 100673–100673. 6 indexed citations

Allweiss, Lena, Katja Giersch, Tassilo Volz, et al.. (2021). Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo. Gut. 71(2). 372–381. 60 indexed citations

Giersch, Katja, Tassilo Volz, Lena Allweiss, et al.. (2021). Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice. Frontiers in Microbiology. 12. 671466–671466. 4 indexed citations

Wisskirchen, Karin, Janine Kah, Antje Malo, et al.. (2019). T cell receptor grafting allows virological control of hepatitis B virus infection. Journal of Clinical Investigation. 129(7). 2932–2945. 59 indexed citations

Klumpp, Klaus, Takashi Shimada, Lena Allweiss, et al.. (2017). Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection. Gastroenterology. 154(3). 652–662.e8. 78 indexed citations

Kah, Janine, Sarene Koh, Tassilo Volz, et al.. (2017). Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection. Journal of Clinical Investigation. 127(8). 3177–3188. 89 indexed citations

Allweiss, Lena, Tassilo Volz, Katja Giersch, et al.. (2017). Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo. Gut. 67(3). 542–552. 136 indexed citations

10.

Bierwolf, Jeanette, Tassilo Volz, Marc Lütgehetmann, et al.. (2016). Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer. Tissue Engineering Part A. 22(9-10). 742–753. 11 indexed citations

11.

Seitz, Stefan, Tassilo Volz, Walter Mier, et al.. (2016). A Slow Maturation Process Renders Hepatitis B Virus Infectious. Cell Host & Microbe. 20(1). 25–35. 49 indexed citations

12.

Giersch, Katja, Lena Allweiss, Tassilo Volz, et al.. (2015). Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. Journal of Hepatology. 63(2). 346–353. 97 indexed citations

13.

Allweiss, Lena, Tassilo Volz, Marc Lütgehetmann, et al.. (2013). Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. Journal of Hepatology. 60(3). 500–507. 70 indexed citations

14.

Bierwolf, Jeanette, Marc Lütgehetmann, Tassilo Volz, et al.. (2012). Primary Human Hepatocytes from Metabolic-Disordered Children Recreate Highly Differentiated Liver-Tissue-Like Spheroids on Alginate Scaffolds. Tissue Engineering Part A. 18(13-14). 1443–1453. 11 indexed citations

15.

Volz, Tassilo, Lena Allweiss, Michael Warlich, et al.. (2012). The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. Journal of Hepatology. 58(5). 861–867. 247 indexed citations

16.

Weber, Kristoffer, Michael Thomaschewski, Michael Warlich, et al.. (2011). RGB marking facilitates multicolor clonal cell tracking. Nature Medicine. 17(4). 504–509. 111 indexed citations

17.

Dandri, Maura, John M. Murray, Marc Lütgehetmann, et al.. (2008). Virion half‐life in chronic hepatitis B infection is strongly correlated with levels of viremia†. Hepatology. 48(4). 1079–1086. 55 indexed citations

18.

Volz, Tassilo, Marc Lütgehetmann, P. Wachtler, et al.. (2007). Impaired Intrahepatic Hepatitis B Virus Productivity Contributes to Low Viremia in Most HBeAg-Negative Patients. Gastroenterology. 133(3). 843–852. 159 indexed citations

19.

Dandri, Maura, Marc Lütgehetmann, Tassilo Volz, & Jörg Petersen. (2006). Small Animal Model Systems for Studying Hepatitis B Virus Replication and Pathogenesis. Seminars in Liver Disease. 26(2). 181–191. 29 indexed citations

20.

Dandri, Maura, Tassilo Volz, Marc Lütgehetmann, & J. Petersen. (2005). Animal models for the study of HBV replication and its variants. Journal of Clinical Virology. 34. S54–S62. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact